MACQUARIE GROUP LTD - THERAVANCE BIOPHARMA INC ownership

THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 116 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
MACQUARIE GROUP LTD ownership history of THERAVANCE BIOPHARMA INC
ValueSharesWeighting
Q3 2023$1,802,000
-16.6%
208,7830.0%0.00%0.0%
Q2 2023$2,161,000
-4.6%
208,7830.0%0.00%
-33.3%
Q1 2023$2,265,000
-3.3%
208,7830.0%0.00%0.0%
Q4 2022$2,343,000
+7.6%
208,783
-2.5%
0.00%0.0%
Q3 2022$2,177,000
+11.9%
214,079
-0.3%
0.00%
+50.0%
Q2 2022$1,946,000
-5.2%
214,7120.0%0.00%0.0%
Q1 2022$2,053,000
-13.5%
214,7120.0%0.00%0.0%
Q4 2021$2,373,000
+49.3%
214,7120.0%0.00%
+100.0%
Q3 2021$1,589,000
-62.3%
214,712
-26.0%
0.00%
-66.7%
Q2 2021$4,215,000
+153.5%
290,258
+256.3%
0.00%
+50.0%
Q1 2021$1,663,000
+33.6%
81,475
+16.3%
0.00%0.0%
Q4 2020$1,245,000
+63.8%
70,058
+36.3%
0.00%
+100.0%
Q3 2020$760,000
-32.0%
51,383
-3.5%
0.00%
-50.0%
Q2 2020$1,117,000
+36.2%
53,237
+6.5%
0.00%0.0%
Q4 2015$820,000
+49.1%
50,0000.0%0.00%
+100.0%
Q3 2015$550,000
-15.5%
50,0000.0%0.00%0.0%
Q2 2015$651,000
-25.0%
50,0000.0%0.00%
-50.0%
Q1 2015$868,000
-25.0%
50,000
-35.5%
0.00%0.0%
Q4 2014$1,157,00077,5480.00%
Other shareholders
THERAVANCE BIOPHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Link Fund Solutions Ltd 5,251,349$135,459,00069.86%
Chescapmanager LLC 949,006$24,570,0003.61%
Baupost Group 9,309,168$241,014,0002.66%
Rock Springs Capital Management LP 655,200$16,963,0000.54%
Rubric Capital Management LP 173,400$4,489,0000.51%
Newtyn Management, LLC 173,300$4,487,0000.41%
NJ State Employees Deferred Compensation Plan 38,142$988,0000.17%
King Wealth Management Group 22,500$583,0000.15%
Virtus ETF Advisers LLC 29,216$756,0000.12%
JACOBS LEVY EQUITY MANAGEMENT, INC 452,615$11,718,0000.12%
View complete list of THERAVANCE BIOPHARMA INC shareholders